Endocrine Practice
Издатель: Elsevier · ISSN 1530-891X · 79 статей
- Composite Pheochromocytomas: More Common Than Expected and Associated With Distinct Clinical Profile
- Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma Remission
- Rare Causes of Pediatric Primary Adrenal Insufficiency: An Observational Cohort Study
- Once-Weekly Insulin Icodec: Safety Profile in Type 2 and Type 1 Diabetes Based on a Pooled Analysis of ONWARDS 1-6
- Continuous Glucose Monitoring for Postkidney Transplantation in Patients With Pre-existing Type 2 Diabetes
- Divergent Risks of Endocrine and Nonendocrine Malignancies in GLP-1 Receptor Agonist Users: A Propensity-Matched Real-World Analysis of Over 140 000 Patients
- Early Postoperative Intact Parathyroid Hormone Dynamics After Curative Parathyroidectomy for Sporadic Primary Hyperparathyroidism: Trajectories, Predictors of Eucalcemic PTH Elevation, and 18-Month Outcomes
- Age as a Risk Stratification Factor in Surgically Treated Low-Risk Indeterminate Thyroid Nodules: Insight From the TIRETA Study
- Long-Term Antithyroid Drug Therapy in the Management of Graves’ Hyperthyroidism: An Updated Narrative Review
- North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules
- North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Low Risk Papillary Thyroid Carcinoma
- Preoperative Preparation With Selective versus Nonselective Alpha-Adrenoceptor Blockade for Pheochromocytomas and Paragangliomas: A Systematic Review and Updated Meta-Analysis
- Latest Advances in Therapeutic Recommendations for Managing Type 2 Diabetes in People Who Fast During Ramadan
- Correlating Menstrual Cycles and Cystic Fibrosis Symptoms in the Era of Highly Effective Modulators: Findings of the MENSTRUAL Study
- Impact of Genetics on Endocrine Manifestations of Cystic Fibrosis
- Reproductive Considerations in Females With Cystic Fibrosis
- Updates in Cystic Fibrosis–Related Diabetes (CFRD)
- Beyond Survival: Advancing Endocrine and Reproductive Health in Cystic Fibrosis
- Right-Dosing, Not Underdosing: Rethinking Microdosing in Endocrinology
- Is the Etoposide, Doxorubicin, and Cisplatin Plus Mitotane Regimen Able to Prolong Survival in Patients With Metastatic Adrenocortical Carcinoma?
- From Algorithms to Adaptive Clinical Intelligence in Diabetes Care
- Calibrating ACTH–DHEA-S and Late-Night Cortisol for MACS: Avoiding a “Good Score” Used Badly
- Role of Nocturnal Cortisol and Catecholamines in the Pathophysiology of Nondipping Blood Pressure in Type 1 Diabetes Mellitus
- Neurocognitive Outcomes in Patients With Pituitary Adenomas
- When Does Polyendocrine Metabolic Ovarian Syndrome (PMOS) Change Definition? A Lifespan Perspective on Menopause and Metabolic Health
- Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings
- Clinical Feasibility of a Low-Dose Tirzepatide Strategy in Older Adults With Type 2 Diabetes: Persistence, Metabolic Benefit, and Treatment Simplification in a Real-World Cohort
- Locally Advanced Disease and Clinical Outcomes of Pheochromocytomas and Paragangliomas: Insights From a Multicenter Study
- Transition From Pediatric to Adult Care for Patients With Type 1 Diabetes Mellitus: More Than Just a Handover
- A Real-World Beta-Cell Preservation Framework in Type 1 Diabetes: Consensus From the T1D Exchange (T1DX-QI)